All News

Understanding specialty drug pricing, and the flow of health care dollars through the lens of the stakeholders involved.

Privately-insured patients with follicular lymphoma (FL) have nearly 2-fold better survival outcomes compared with publicly-insured or non-insured patients, according to a new study.

Interventions must address HIV testing and beliefs among both patients and providers in order to reach underserved populations.

The use of benzodiazepines and related z-drugs was found to be associated with a modest increase in the risk of Alzheimer disease in a case-control trial.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Pharmacy students should take the pressure off themselves and think about their next steps, not the rest of their careers.

Study evaluates the effect of multiple sclerosis treatment alemtuzumab (Lemtrada) on the B-cell component of MS.

The prescribing limits are designed to help prevent patients from receiving unnecessary opioid pills after surgery.

The CDC is Partnering with the American Optometric Association to bring inform patients about proper lens care, during Contact Lens Awareness Week.

New study finds that privately-insured patients with follicular lymphoma have better survival outcomes.

Persistent use of osteoporosis medications was associated with reduced risk of fracture and significantly lower total healthcare costs, a recent analysis of Medicare claims data found.

Officials with the FDA have given approval for marketing Brainsway’s Deep Transcranial Magnetic Stimulation System for treatment of obsessive compulsive disorder.

Testing individuals not considered high-risk for hepatitis C virus addresses increase in new infections associated with opioid epidemic.

Celtaxsys’ acebilustat is the first novel anti-inflammatory molecule with the potential to both reduce pulmonary exacerbations and prolong time to first exacerbation.

The rate of disease progression in patients with rheumatoid arthritis (RA) can be associated with a poor prognosis in patients.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Can you solve the pharmaceutical mystery? Each week, a new case study is presented.

Sun Pharmaceutical's cyclosporine ophthalmic solution is the first and only dry eye treatment to combine cyclosporine A with nanomicellar technology, according to the company.

With this approval, nivolumab (Opdivo) offers a new treatment option for patients with small cell lung cancer whose cancer has progressed after 2 or more prior lines of therapy.

Two new studies highlight trends in life expectancy and mortality across high-income countries, citing worsening health in the United States.

Assessment of neurofilament light chain levels offers real-time, efficient measure marker of multiple sclerosis progression.

Childhood exposure to secondhand smoke may heighten the risk of developing rheumatoid arthritis (RA) later in life, even in non-smokers, according to new research.

States that chose to expand Medicaid eligibility under the Affordable Care Act (ACA) have seen a greater decrease in uninsured rates among low-income patients.

Top news of the week from Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

A young patient, aged 11 months, suffered a stroke after being infected with the varicella zoster virus, commonly known as chickenpox.

The FDA has approved the first generic epinephrine auto-injector for the emergency treatment of allergic reactions, including anaphylaxis.